To include your compound in the COVID-19 Resource Center, submit it here.

Aimmune, Regeneron teaming up for peanut allergy trial

Aimmune Therapeutics Inc. (NASDAQ:AIMT) said it will collaborate with Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi (Euronext:SAN; NYSE:SNY)

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE